1995: Year Of Consolidation For Sanofi

1 September 1996

Jean-Francois Dehecq, chairman of French health and beauty company Sanofi, told the firm's shareholders at the recent annual general meeting that 1995 was, above all, a year of consolidation, since Sanofi had to integrate all the business activities acquired from Sterling Winthrop in 1994. This was done successfully in the established time frame.

Another form of consolidation has been the increase in the firm's stake in the Hungarian drug company, Chinoin (Marketletters passim). In central and eastern Europe, in addition to the bridgehead represented by Chinoin, Sanofi is present in over 20 markets through representative offices and subsidiaries and is actively preparing further operations to bolster its presence locally.

In 1995, the firm was also particularly active in Asia, where it created a joint venture in China and increased its shareholding in its Vietnamese subsidiary, and in the beginning of 1996, it signed a joint venture agreement in India with Torrent Pharmaceuticals.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight